AMAT
24
-7
EMN
46
-2
SHW
50
-3
HRL
38
-7
BBY
34
-7
UHS
55
-3
EQIX
45
3
APD
37
-3
CHD
51
-7
HP
32
2
TXT
46
-2
PNR
39
-2
EW
27
7
DD
34
-2
CSCO
50
2
XOM
56
2
MKC
66
-2
NRG
54
9
ICE
69
3
MHK
40
3
AMAT
24
-7
EMN
46
-2
SHW
50
-3
HRL
38
-7
BBY
34
-7
UHS
55
-3
EQIX
45
3
APD
37
-3
CHD
51
-7
HP
32
2
TXT
46
-2
PNR
39
-2
EW
27
7
DD
34
-2
CSCO
50
2
XOM
56
2
MKC
66
-2
NRG
54
9
ICE
69
3
MHK
40
3
Financhill
Back

Preformed Line Products Vs. Sarepta Therapeutics Industry Stock Comparison

Sell
36

PLPC
Preformed Line Products

Last Price:
$123.68
Seasonality Move:
8.98%
Buy
55

SRPT
Sarepta Therapeutics

Last Price:
$98.39
Seasonality Move:
6.73%
Sell
36
Preformed Line Products (PLPC) is a Sell

Is Preformed Line Products a Buy, Sell or Hold?

  • The current Preformed Line Products [PLPC] share price is $123.00. The Score for PLPC is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
  • PLPC is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
55
Sarepta Therapeutics (SRPT) is a Buy

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $99.77. The Score for SRPT is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
  • SRPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

PLPC Stock Price Chart

What is Preformed Line Products's stock price today?

  • The Preformed Line Products share price today is $123.00
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PLPC is experiencing slight selling pressure.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $99.77
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.

PLPC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -4.28 Sell
Relative Strength Index (14 RSI): 35.8 Sell
Chaikin Money Flow: -4205 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (126.45 - 143.89) Sell
Bollinger Bands (100): (124.8 - 139.84) Sell

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.4 Sell
Relative Strength Index (14 RSI): 37.2 Sell
Chaikin Money Flow: -420668 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (103.16 - 112.22) Sell
Bollinger Bands (100): (109.63 - 127.19) Sell

PLPC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 123.84 Sell
20-day SMA: 132.73 Sell
50-day SMA: 133.32 Sell
200-day SMA: 127.99 Sell
8-day EMA: 124.78 Sell
20-day EMA: 130.01 Sell
50-day EMA: 132.61 Sell
200-day EMA: 130.18 Sell

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 103.49 Sell
20-day SMA: 106.07 Sell
50-day SMA: 113.88 Sell
200-day SMA: 126.52 Sell
8-day EMA: 103.1 Sell
20-day EMA: 106.21 Sell
50-day EMA: 111.8 Sell
200-day EMA: 120.79 Sell

Preformed Line Products Earnings Growth & PLPC Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.52 per share, an increase next quarter of $0.05 per share, an increase this year of $6.65 per share, and an increase next year of $5.25 per share.

Preformed Line Products Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):